Autoantibodies against the amino terminal of α-enolase are a useful diagnostic marker of Hashimoto's encephalopathy
Authors:
- M. YonedaMYM. Yoneda
- T. ItoTIT. Ito
- O. YamamuraOYO. Yamamura
- S. SatomiSSS. Satomi
- H. HigaHHH. Higa
- A. KimuraAKA. Kimura
- M. SuzukiMSM. Suzuki
- M. YamashitaMYM. Yamashita
- T. YuasaTYT. Yuasa
- H. SuzukiHSH. Suzuki
- M. KuriyamaMKM. Kuriyama
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 162 (1-2) , 130-136
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerationsJournal of the Neurological Sciences, 2004
- Creutzfeldt-Jakob disease associated with high titer of antithyroid autoantibodies: case report and literature reviewNeurological Sciences, 2003
- Antithyroid antibodies in the CSFNeurology, 2003
- Hashimoto EncephalopathyArchives of Neurology, 2003
- Surface expression of a glycolytic enzyme, α‐enolase, recognized by autoantibodies in connective tissue disordersEuropean Journal of Immunology, 2000
- In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitopeNature Medicine, 2000
- Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?Movement Disorders, 1996
- Electroencephalographic findings in Hashimoto's encephalopathyNeurology, 1995
- Mapping of isozymic differences in enolaseInternational Journal of Biological Macromolecules, 1991
- HASHIMOTO'S DISEASE AND ENCEPHALOPATHYThe Lancet, 1966